Emergence of adhfrMutation Conferring High‐Level Drug Resistance inPlasmodium falciparumPopulations from Southwest Uganda

This publication has 64 references indexed in Scilit:

• Antifolate Resistance inPlasmodium falciparum:Multiple Origins and Identification of NoveldhfrAlleles
  The Journal of Infectious Diseases, 2006
• Geographic Differences in Antimalarial Drug Efficacy in Uganda Are Explained by Differences in Endemicity and Not by Known Molecular Markers of Drug Resistance
  The Journal of Infectious Diseases, 2006
• FREQUENCY DISTRIBUTION OF ANTIMALARIAL DRUG-RESISTANT ALLELES AMONG ISOLATES OF PLASMODIUM FALCIPARUM IN BANGUI, CENTRAL AFRICAN REPUBLIC
  The American Journal of Tropical Medicine and Hygiene, 2006
• Mutations Associated with Sulfadoxine-Pyrimethamine and Chlorproguanil Resistance in Plasmodium falciparum Isolates from Blantyre, Malawi
  Antimicrobial Agents and Chemotherapy, 2005
• Why has the dihydrofolate reductase 164 mutation not consistently been found in Africa yet?
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 2005
• Artesunate–dapsone–proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 2005
• Relationship between age, molecular markers, and response to sulphadoxine–pyrimethamine treatment in Kampala, Uganda
  Tropical Medicine & International Health, 2004
• Highly pyrimethamine-resistant alleles of dihydrofolate reductase in isolates of Plasmodium falciparum from Tanzania
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 2002
• Polyclonal Plasmodium falciparum malaria in travelers and selection of antifolate mutations after proguanil prophylaxis.
  The American Journal of Tropical Medicine and Hygiene, 2002
• Advances in the study of Afrotropical vectors
  Pathogens and Global Health, 1997